Mounjaro vs Wegovy: which is safer? It's one of the most common questions we're asked, and the honest answer is that neither medicine is dramatically "safer" than the other. Both are prescription-only GLP-1 based injections with very similar side-effect profiles and the same rare-but-serious risks. What actually keeps you safe is careful prescribing, slow dose increases and reporting anything unusual. Here is the fair, evidence-first head-to-head.
On safety the two are close cousins. Wegovy (semaglutide) has the longer real-world track record, while Mounjaro (tirzepatide) is newer but has a large trial base and NICE approval. Side effects overlap heavily and the serious risks are the same in kind. The "safer" choice is the one a prescriber judges right for your health history — taken at a dose you tolerate.
Mounjaro vs Wegovy: which is safer on paper?
Wegovy is a brand of semaglutide, a GLP-1 receptor agonist. The same molecule has been used in diabetes care (as Ozempic) for years, so its safety data stretches back further. That longer history is why some people instinctively feel it is the safer bet.
Mounjaro is a brand of tirzepatide, a dual GIP and GLP-1 receptor agonist. It is the newer medicine, but it went through large, rigorous trials (the SURMOUNT programme) and is MHRA-licensed and NICE-recommended (TA1026, December 2024). "Newer" is not the same as "riskier" — it simply means fewer years of post-marketing use than semaglutide.
Common side effects: near-identical
The everyday side effects of both medicines are overwhelmingly gastrointestinal, and they look almost the same:
- Mounjaro: nausea, diarrhoea, constipation, vomiting, tiredness
- Wegovy: nausea, diarrhoea, vomiting, constipation, headache
For most people these are mildest at the start, flare briefly after each dose increase, then settle as the body adjusts. Both medicines are deliberately started low and increased slowly — a titration schedule — precisely to keep these symptoms manageable. That gradual approach is a safety feature, not a marketing quirk.
Serious risks: the same list for both
When it comes to rare but serious risks, Mounjaro and Wegovy share essentially the same warnings:
- Pancreatitis (rare) — severe, persistent tummy pain that may spread to the back needs urgent attention.
- Gallstones — rapid weight loss of any kind can raise the risk.
- Dehydration and kidney strain — from prolonged vomiting or diarrhoea.
- Low blood sugar — mainly a concern if combined with insulin or a sulfonylurea.
Because the risk categories match, no responsible source can claim one is meaningfully "safer" on this front. What matters far more is honest screening: your prescriber should ask about pancreatitis history, gallbladder problems, thyroid conditions, pregnancy plans and other medicines before either is dispensed.
Whichever you take, report any suspected side effect through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk. It is quick, and it helps build the safety picture for everyone.
Safety at a glance
| Dimension | Mounjaro (tirzepatide) | Wegovy (semaglutide) |
|---|---|---|
| Drug class | Dual GIP + GLP-1 | GLP-1 receptor agonist |
| Track record | Newer; large trial base | Longer real-world history |
| Common effects | Nausea, diarrhoea, constipation, vomiting, tiredness | Nausea, diarrhoea, vomiting, constipation, headache |
| Serious risks | Pancreatitis, gallstones, dehydration, low blood sugar | Pancreatitis, gallstones, dehydration, low blood sugar |
| Starter dose | 2.5 mg weekly for 4 weeks | 0.25 mg weekly for 4 weeks |
| Maximum dose | 15 mg | 2.4 mg |
| UK status | MHRA-licensed; NICE TA1026 | MHRA-licensed; NICE-approved |
Does more weight loss mean more risk?
Mounjaro tends to produce more weight loss on average — around 21–22% at higher doses in SURMOUNT-1 versus roughly 15% for Wegovy in STEP 1, with SURMOUNT-5 showing about 20% against 14% head-to-head. A reasonable worry is whether the more powerful medicine is also the riskier one.
The evidence so far doesn't support that simple equation. Both medicines climb through the same kind of careful titration, and the trial safety profiles are broadly comparable. Faster weight loss can, however, nudge up the chance of gallstones, so hydration, sensible eating and staying in touch with your prescriber matter on either drug. For the numbers behind the results, see our results comparison and the full side-effects breakdown.
How to make either one safer
The biggest safety lever is not which brand you pick — it's how the treatment is run. That means a proper prescriber assessment, honest disclosure of your medical history, a slow dose climb, and regular reviews so problems are caught early. Ongoing check-ins beat a one-off online form every time.
Our recommended provider, The Weight Clinic, offers both medicines with monthly video reviews, a refund if the prescriber declines you, and £35 off your first order with code NEWME — a sensible way to start either safely, with a clinician actually watching how you get on.
A word on unregulated "alternatives"
The single most dangerous thing you can do is buy tirzepatide or semaglutide from a source that isn't a GPhC-registered pharmacy or CQC-regulated clinic. Steer clear of "compounded" versions, grey-market vials and anything sold without a prescriber. These bypass the exact safeguards this whole article is about. Always confirm registration before you order.
Price: safety is priced in with regulated providers
Sticking to legitimate providers doesn't have to mean overpaying. Below are ongoing (post-promo) starter prices at a spread of GPhC-registered and CQC-regulated providers, last checked 25 August 2026.
| Provider | Mounjaro 2.5mg | Wegovy 0.25mg |
|---|---|---|
| Boots Online Doctor | £179 | £89 |
| Chemist4U | £148 (£122 first month) | £99 (£73 first month) |
| The Weight Clinic | £160 (£125 first month) | £115 (£80 first month) |
| ZAVA | £169.99 | £99.99 |
| Numan | £219 | £149 |
Prices are set by each pharmacy and change often, so confirm on the provider's own site before ordering. For every dose and provider, see the homepage price table, our cost per month guide and the overall Mounjaro or Wegovy verdict.
FAQ
Is Mounjaro or Wegovy safer overall?
Neither is clearly safer. Their common side effects and serious risks are broadly the same. Wegovy has a longer real-world track record, while Mounjaro is newer but well-studied and NICE-approved. The safest choice is the one a prescriber matches to your health history.
Which has more side effects?
They are very similar. Both most commonly cause nausea, diarrhoea, vomiting and constipation, usually worst after starting or increasing a dose and easing over time. Slow titration is used with both to keep symptoms manageable.
Does Mounjaro's stronger effect make it riskier?
The current evidence doesn't show that. Despite producing more average weight loss, Mounjaro's safety profile is comparable to Wegovy's. Rapid weight loss on either can slightly raise gallstone risk, so hydration and regular reviews help.
What serious risks should I watch for?
For both medicines: pancreatitis (rare, causing severe tummy pain), gallstones, dehydration and kidney strain from heavy vomiting, and low blood sugar if combined with insulin or a sulfonylurea. Report any suspected reaction via the MHRA Yellow Card scheme.
How can I take either medicine more safely?
Use a GPhC-registered pharmacy or CQC-regulated clinic, disclose your full medical history, follow the slow dose schedule, stay hydrated and attend reviews. Avoid unregulated or "compounded" sellers entirely.
Can I switch between them if one doesn't suit me?
Yes, many people move from Wegovy to Mounjaro or back, always under a prescriber who resets the starter dose. See our guide on switching from Wegovy to Mounjaro for the practical steps.
The Weight Clinic prescribes both Mounjaro and Wegovy with monthly video reviews and a refund if the prescriber declines you. Get £35 off your first order with code NEWME. This is price and information only, not medical advice — a prescriber decides what's suitable for you.
Mounjaro and Wegovy are prescription-only medicines. This article is for information and price comparison, not medical advice. Read our full Mounjaro vs Wegovy comparison for the complete picture.